Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vaskar Saha

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Haematologica|September 15, 2018
Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: high white blood cell count at diagnosis is the strongest prognostic factorAndrea Biondi, Gunnar Cario, Paola De Lorenzo, et al.
The Lancet Regional Health. Southeast Asia|June 9, 2025
Risk stratified treatment for childhood acute lymphoblastic leukaemia: a multicentre observational study from IndiaManash Pratim Gogoi, Parag Das, Nandana Das, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2010
Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005Maurizio Aricò, Martin Schrappe, Stephen P Hunger, et al.
Plos One|October 4, 2014
Outcome of central nervous system relapses in childhood acute lymphoblastic leukaemia--prospective open cohort analyses of the ALLR3 trialAshish Narayan Masurekar, Catriona A Parker, Milensu Shanyinde, et al.
Leukemia|November 13, 2025
Blinatumomab consolidation in children with high-risk first-relapse B-cell precursor acute lymphoblastic leukemia: final 5-year follow-up analysis of a randomized multicenter phase 3 studyFranco Locatelli, Carmelo Rizzari, Bernd Gruhn, et al.
Blood|May 25, 2011
RAC2, AEP, and ICAM1 expression are associated with CNS disease in a mouse model of pre-B childhood acute lymphoblastic leukemiaMark Holland, Fernanda V Castro, Seema Alexander, et al.
The Journal of Clinical Investigation|June 11, 2009
A dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug L-asparaginaseNaina Patel, Shekhar Krishnan, Marc N Offman, et al.
European Journal of Cancer (Oxford, England : 1990)|September 10, 2019
Impact of dose and duration of therapy on dexamethasone pharmacokinetics in childhood acute lymphoblastic leukaemia-a report from the UKALL 2011 trialRosanna K Jackson, Martina Liebich, Philip Berry, et al.
Blood|December 25, 2013
IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALLArian van der Veer, Marketa Zaliova, Federica Mottadelli, et al.
Pediatric Blood & Cancer|March 16, 2026
Facilitators and Barriers for Implementing Diagnostic Sequencing Technology for Pediatric Oncology in Low- and Middle-Income CountriesKenneth M Busby, Nathaniel Webb, Javeria Aijaz, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Haematologica|September 15, 2018
Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: high white blood cell count at diagnosis is the strongest prognostic factorAndrea Biondi, Gunnar Cario, Paola De Lorenzo, et al.
The Lancet Regional Health. Southeast Asia|June 9, 2025
Risk stratified treatment for childhood acute lymphoblastic leukaemia: a multicentre observational study from IndiaManash Pratim Gogoi, Parag Das, Nandana Das, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2010
Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005Maurizio Aricò, Martin Schrappe, Stephen P Hunger, et al.
Plos One|October 4, 2014
Outcome of central nervous system relapses in childhood acute lymphoblastic leukaemia--prospective open cohort analyses of the ALLR3 trialAshish Narayan Masurekar, Catriona A Parker, Milensu Shanyinde, et al.
Leukemia|November 13, 2025
Blinatumomab consolidation in children with high-risk first-relapse B-cell precursor acute lymphoblastic leukemia: final 5-year follow-up analysis of a randomized multicenter phase 3 studyFranco Locatelli, Carmelo Rizzari, Bernd Gruhn, et al.
Blood|May 25, 2011
RAC2, AEP, and ICAM1 expression are associated with CNS disease in a mouse model of pre-B childhood acute lymphoblastic leukemiaMark Holland, Fernanda V Castro, Seema Alexander, et al.
The Journal of Clinical Investigation|June 11, 2009
A dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug L-asparaginaseNaina Patel, Shekhar Krishnan, Marc N Offman, et al.
European Journal of Cancer (Oxford, England : 1990)|September 10, 2019
Impact of dose and duration of therapy on dexamethasone pharmacokinetics in childhood acute lymphoblastic leukaemia-a report from the UKALL 2011 trialRosanna K Jackson, Martina Liebich, Philip Berry, et al.
Blood|December 25, 2013
IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALLArian van der Veer, Marketa Zaliova, Federica Mottadelli, et al.
Pediatric Blood & Cancer|March 16, 2026
Facilitators and Barriers for Implementing Diagnostic Sequencing Technology for Pediatric Oncology in Low- and Middle-Income CountriesKenneth M Busby, Nathaniel Webb, Javeria Aijaz, et al.
Pageof 9